Cross Country Healthcare Inc (CCRN)
Return on equity (ROE)
Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
---|---|---|---|---|---|---|
Net income | US$ in thousands | 72,631 | 188,461 | 132,002 | -12,962 | -57,713 |
Total stockholders’ equity | US$ in thousands | 473,393 | 457,219 | 297,528 | 154,375 | 162,632 |
ROE | 15.34% | 41.22% | 44.37% | -8.40% | -35.49% |
December 31, 2023 calculation
ROE = Net income ÷ Total stockholders’ equity
= $72,631K ÷ $473,393K
= 15.34%
Cross Country Healthcares, Inc.'s return on equity (ROE) has fluctuated significantly over the past five years. In 2023, the ROE stood at 15.34%, a decrease from the previous year's level of 41.22%. The company's ROE was highest in 2021 at 44.37%, indicating strong profitability relative to shareholder equity. However, in 2020 and 2019, the ROE was negative, with a particularly low figure of -35.49% in 2019, suggesting that the company experienced challenges in generating profits compared to its equity base.
Overall, Cross Country Healthcares, Inc.'s ROE has shown inconsistency and variability, indicating fluctuations in profitability and efficiency in utilizing shareholder equity to generate returns over the years analyzed. Further analysis of the company's financial performance and operational efficiency may be necessary to understand the factors influencing these fluctuations in ROE.
Peer comparison
Dec 31, 2023